Offer - Urjas Oil for just ₹ 1 X
Emzosin D is an allopathic medicine The correct dosage of Emzosin D depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Emzosin D is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Emzosin D safe for pregnant women?
Pregnant women may get severe side effects after taking Emzosin D. If you are pregnant, do not take Emzosin D without a doctor's advice.
Is the use of Emzosin D safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Emzosin D. It should only be taken after medical advice.
What is the effect of Emzosin D on the Kidneys?
Emzosin D is completely safe for kidneys.
What is the effect of Emzosin D on the Liver?
The liver can be affected by Emzosin D. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Emzosin D only after medical advice.
What is the effect of Emzosin D on the Heart?
Using Emzosin D does not have any harmful effects on the heart.
Emzosin D should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emzosin D unless your doctor advises you to do so -
Is this Emzosin D habit forming or addictive?
Forming a habit of Emzosin D has not been reported.
Interaction between Food and Emzosin D
Information is not available on the interaction of any foods with Emzosin D, due to a lack of research on this.
Interaction between Alcohol and Emzosin D
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Emzosin D.
No, Emzosin D is a prescription drug, so do not take it without consulting a doctor. It can be harmful for the patient to take this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before taking this medication by himself or herself.
Yes, Emzosin D might lower blood pressure (hypotension). It occurs due to vasodilation (widening of the blood vessels) because it inhibits the effect of certain chemical messengers (adrenaline and noradrenaline) that results in low blood pressure. If you are experiencing dizziness or lightheadedness after taking this drug which is a symptom of low blood pressure, then you are advised to lay down immediately till it subsides and drink salty water.
Take Emzosin D 1-2 times in a day or as advised by your doctor. It has to be taken with food because of the presence of food assists in the better absorption of this drug from the stomach. Precautions must be taken in patients with heart diseases, improper liver or kidney function.
No, Emzosin D and metoprolol should not be taken together because metoprolol is an antihypertensive drug which lowers the blood pressure and Emzosin D might also lower the blood pressure. Hence, you are advised to avoid taking Emzosin D and metoprolol together.
No, Emzosin D and ibuprofen should not be taken together at the same time because ibuprofen decreases the effects of alfuzosin by interfering in its working mechanism. Hence you are advised to avoid taking Emzosin D and ibuprofen together at the same time.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Uroxatral® (alfuzosin HCL)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 123-124
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)